GIUNTI, DEBORA
 Distribuzione geografica
Continente #
EU - Europa 4.644
NA - Nord America 874
AS - Asia 620
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 15
OC - Oceania 1
Totale 6.269
Nazione #
IT - Italia 4.534
US - Stati Uniti d'America 802
SG - Singapore 267
CN - Cina 143
VN - Vietnam 108
CA - Canada 40
BR - Brasile 37
FR - Francia 34
BD - Bangladesh 33
HK - Hong Kong 24
GB - Regno Unito 16
MX - Messico 12
FI - Finlandia 11
AR - Argentina 9
DE - Germania 9
ID - Indonesia 7
JP - Giappone 7
TR - Turchia 6
CH - Svizzera 5
IL - Israele 5
IQ - Iraq 5
JM - Giamaica 5
PL - Polonia 5
CO - Colombia 4
CR - Costa Rica 4
HN - Honduras 4
UA - Ucraina 4
CL - Cile 3
EC - Ecuador 3
IN - India 3
PE - Perù 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
ZA - Sudafrica 3
DZ - Algeria 2
EE - Estonia 2
ES - Italia 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
NL - Olanda 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
ET - Etiopia 1
IE - Irlanda 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MW - Malawi 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 6.219
Città #
Genova 2.227
Genoa 1.388
Rapallo 451
Vado Ligure 323
San Jose 179
Singapore 152
Ashburn 107
Ho Chi Minh City 31
Council Bluffs 30
Hanoi 29
Lauterbourg 28
Beijing 27
New York 24
Hong Kong 21
Bordighera 14
Santa Clara 13
Los Angeles 12
Phoenix 12
Helsinki 11
Rome 11
Atlanta 9
Milan 9
Frankfurt am Main 8
Chicago 7
Mexico City 7
Montreal 7
Brooklyn 6
Buffalo 6
Da Nang 6
Naples 6
Orem 6
São Paulo 6
Tokyo 6
Turin 6
Baltimore 5
Newark 5
Philadelphia 5
Carrboro 4
Florence 4
Memphis 4
Phủ Lý 4
Baghdad 3
Birmingham 3
Bologna 3
Calgary 3
Cisano Bergamasco 3
Dallas 3
Detroit 3
Haiphong 3
Houston 3
Hải Dương 3
Istanbul 3
Johannesburg 3
Kyiv 3
Ljubljana 3
London 3
Malatya 3
Mugnano di Napoli 3
Sant'Anastasia 3
Stockton 3
Tampa 3
Tianjin 3
Trento 3
Washington 3
Winnipeg 3
Zurich 3
Albany 2
Amman 2
Ananindeua 2
Ancona 2
Asunción 2
Athens 2
Basingstoke 2
Baton Rouge 2
Braga 2
Brampton 2
Bratislava 2
Brentwood 2
Cerea 2
Charlotte 2
Clifton 2
Dearborn 2
Denver 2
Dundalk 2
Fort Lauderdale 2
Ha Long 2
Kapolei 2
Kaufman 2
Krakow 2
Livorno 2
Midlothian 2
Milwaukee 2
Moncalieri 2
Moncton 2
Nairobi 2
Oberengstringen 2
Orange Park 2
Osio Sopra 2
Piscataway 2
Port of Spain 2
Totale 5.359
Nome #
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 230
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 229
Neuroprotective features of mesenchymal stem cells. 226
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 212
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 208
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 204
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 203
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 201
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 198
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 194
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 187
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 178
Human mesenchymal stem cells modulate B-cell functions. 175
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 175
Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 164
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 158
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 156
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis. 156
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 152
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 150
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. 143
Dynamics of the reactivity to MBP in multiple sclerosis. 141
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 139
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 139
Restricted immune responses lead to CNS demyelination and axonal damage. 138
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. 129
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 128
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 126
Mesenchymal stem cells exert their therapeutic effect by inducing microglia to acquire a neuroprotective phenotype 119
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 116
racterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 116
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 114
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 112
MRI and neuropathologic study of eae in the non human primate callithr1x jacchus 108
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 107
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 105
Mesenchimal stem cells exert beneficial effects on microglia 105
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 97
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 87
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 85
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 83
Acute “in vivo” LPS causes an early presynaptic C1q and C3 accumulation and increases the “prunability” of cortical synaptosomes 75
null 1
Totale 6.269
Categoria #
all - tutte 19.694
article - articoli 13.614
book - libri 0
conference - conferenze 6.080
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022323 0 0 0 59 17 15 15 88 15 34 7 73
2022/2023521 42 51 4 50 104 73 4 30 86 7 63 7
2023/2024356 10 22 14 40 45 89 19 31 10 9 16 51
2024/2025866 58 52 24 69 86 88 58 181 28 33 78 111
2025/20261.667 203 43 79 148 256 98 231 95 150 155 105 104
2026/2027600 187 49 165 199 0 0 0 0 0 0 0 0
Totale 6.269